[Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Li Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoyuan Xu(Columbia University), Ming‐Lung Yu(National Sun Yat-sen University), Wengang Li(Xiamen University), Haiying Lu(Shanghai University of Traditional Chinese Medicine), Zhenru Feng(Peking University), Weibo Gong(Suzhou Research Institute), Nu-en-ji-ya Zhao
PubMed
August 1, 2009
Cited by 4
Related Papers
Treatment of chronic hepatitis C in Asia: When East meets West
|Journal of Gastroenterology and Hepatology|2009|262
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
|Diabetes|2014|202
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
|Metabolism|2024|111
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
|The American Journal of Gastroenterology|2019|102